Talking Medicines : Driving more Effective Medicines By Listening to Patient
July 9, 2020

Founders Jo Halliday, CEO and Elizabeth Fairley, COO of Talking Medicines recently collaborated with a US pharma trade publication based out of New York called pharma’s almanac. The article published articulates their views on the opportunities for marketing in pharma companies to use the Talking Medicines patient intelligence to measure their performance and identify strategies for improvement.

pharma's almanac

Talking Medicines feature in pharma’s almanac

 

The voice of the patient has long been underserved in the pharmaceutical industry, despite extensive evidence that listening to patients and learning about their experiences can dramatically improve drug development, delivery, and accessibility, as well as patient support. The platform technology developed by Talking Medicines is designed to report on marketing intelligence for medicines, gathering information about patient experiences with existing drugs to help pharma companies identify barriers to access and opportunities for growth, and to provide enhanced support for optimized health outcomes.

The full article can be found here 

July 2020

 

Recent Blogs

COVID-19 – The catalyst changing our health behaviour

COVID-19 – The catalyst changing our health behaviour

We are in a period of limbo, having apparently weathered phase one of the Corona Virus wave. Now as autumn arrives we are bracing to see if we can avoid another peak over winter. Many of our past activities have resumed; we are back in bars, restaurants, gyms and...

Counterfeit medicines in Africa

Counterfeit medicines in Africa

What is a counterfeit medicine? A counterfeit medicine is a medical product which is substandard or falsified and therefore hasn’t undergone evaluation by any regulatory authority before making it to the correct patients. The WHO estimate that 10% of all medicines in...

Why does ‘Feelings Data’ matter to us?

Why does ‘Feelings Data’ matter to us?

We live in a world in which “feelings” symptoms carry far less gravitas than those that are physical. Though physical traits will always be paramount in disease tracking and treatment, we have realised that acknowledging how patients feel is just as important. Why is...